RxDoctor Payments Data
★ My doctorsLook up a doctor →

Neira Segarra

General Practice · Bayamon, PRNPI 1306824982

Payments from drug & device makers

What this record shows

21 manufacturers reported payments, led by Eli Lilly at 46.1% of the total. Reporting peaked in 2022 at $3,909 and has fallen 93.4% since, to $256 in 2025. Among general practice clinicians in PR with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$10,227in general payments, 2019–2025

Across 121 payments — averaging $84.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Eli Lilly$5K
  • AstraZeneca$1K
  • Lilly USA, LLC$944
  • Teva Pharmaceuticals USA, Inc.$751
  • Merck$497
  • Johnson & Johnson$353
  • plus $2K from 15 others
$4,105in research payments, 2019–2025

Across 17 payments — averaging $241.46 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Regeneron$4K

What the payments were for

  • Travel & lodging$4,34042%
  • Food & beverage$5,88858%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Eli Lilly23$4,712
AstraZeneca19$1,178
Lilly USA, LLC16$944
Teva Pharmaceuticals USA, Inc.15$751
Merck10$497
Johnson & Johnson7$353
Boehringer Ingelheim11$325
Biocryst US Sales Co., LLC2$235
Eli Lilly Export S.A. Puerto Rico Branch3$143
Biohaven Pharmaceuticals, Inc.2$136
Biohaven Pharmaceutical Holding Company Ltd.1$123
Pfizer Pharmaceuticals LLC2$120
E.r. Squibb & Sons, L.L.C.1$108
Exact Sciences1$106
Amgen1$100
Novo Nordisk1$93
Pfizer1$91
AbbVie1$81
GSK1$76
PBG Puerto Rico LLC2$40
Genentech USA, Inc.1$18

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$10,227 in reported general payments places this provider in the 95th percentile of 3,586 general practice providers in Puerto Rico.

See all general practice providers in Puerto Rico →

Most prescribed under Part D

DrugClaimsCost to plans & patients
SynthroidLevothyroxine Sodium16$1,979
Albuterol Sulfate26$462
Dexamethasone13$331
Montelukast Sodium14$301
Temazepam34$267
Prednisone18$117
Pantoprazole Sodium11$109
Hydrochlorothiazide11$88

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieSynthroid$81$1,97916 claims
Teva Pharmaceuticals USA, Inc.Albuterol Sulfate$751$46226 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,586 general practice providers in Puerto Rico.

Other general practice in Bayamon

See the full list for Puerto Rico →

Where these figures come from

Is this you, or does something look wrong? →